One of the most important distinctions in Australia’s vaping landscape is the difference between therapeutic vaping goods and consumer vapes. While the terms are sometimes used interchangeably, they represent very different regulatory categories.
Therapeutic vaping goods are products that fall within the scope of healthcare regulation. They are subject to oversight by the Therapeutic Goods Administration and are supplied within controlled pathways. This affects how they are classified, described, and accessed.
Consumer vapes, by contrast, are typically associated with retail environments in other countries. In Australia, this category has been significantly restricted, particularly where nicotine is involved. As a result, the line between consumer and therapeutic products has shifted over time.
This distinction is also reflected in how information is presented. Therapeutic goods are subject to advertising restrictions, which is why public-facing content is often limited or neutral. Consumer-style promotion is not permitted within this framework.
Understanding this difference helps explain why vaping in Australia looks very different from other markets. It is not simply a variation in availability, but a fundamentally different regulatory approach.
